Samantha J. Paston

University Park
Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

SC134-TCB Targeting Fucosyl-GM1, a T Cell-Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models.

SC134-TCB Targeting Fucosyl-GM1, a T Cell-Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models.

Journal: Molecular cancer therapeutics

Published: March 15, 2024

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.

Journal: Journal for immunotherapy of cancer

Published: September 13, 2023

What do cancer-specific T cells 'see'?

What do cancer-specific T cells 'see'?

Journal: Discovery immunology

Published: September 08, 2022

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.

Journal: Immunology

Published: February 24, 2022

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: January 08, 2022

The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer.

The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: April 16, 2021

Cancer Vaccines, Adjuvants, and Delivery Systems.

Cancer Vaccines, Adjuvants, and Delivery Systems.

Journal: Frontiers in immunology

Published: November 10, 2020

TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.

TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 01, 2019

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules.

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules.

Journal: PloS one

Published: May 17, 2018

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 03, 2015

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

Journal: Oncoimmunology

Published: September 16, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026